Groningen, Netherlands

Thorvald Eelco Wallaart


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006-2009

Loading Chart...
2 patents (USPTO):

Title: The Innovative Journey of Thorvald Eelco Wallaart

Introduction

Thorvald Eelco Wallaart, an accomplished inventor based in Groningen, NL, has made significant contributions to the field of biotechnology. With two notable patents to his name, Wallaart's work is primarily centered around the synthesis of important compounds that have vast applications in medicine.

Latest Patents

Wallaart's latest innovations include a crucial patent for "Transgenic amorpha-4, 11-diene synthesis." This invention describes an isolated DNA sequence that encodes a polypeptide exhibiting the biological activity of amorpha-4,11-diene synthase. This DNA sequence is vital for the transformation of bacteria, yeasts, and plants, enabling them to produce amorpha-4,11-diene—a specific precursor in the synthesis of artemisinin. This compound is essential in the treatment of malaria, making Wallaart's work of immense importance in public health.

Career Highlights

Throughout his career, Wallaart has collaborated with prominent organizations, including Genoclipp Biotechnology B.V. and the Institute for OneWorld Health. His endeavors in these companies underscore his commitment to advancing biotechnological research and innovation.

Collaborations

Wallaart has worked closely with notable colleagues, including Hendrik Jan Bouwmeester. Their collaborative efforts have undoubtedly contributed to the successes and breakthroughs achieved in their respective fields.

Conclusion

Thorvald Eelco Wallaart's innovative pursuits and his contributions to biotechnology illuminate the vital role inventors play in enhancing medical advancements. With his research and patents, he continues to impact the industry positively, paving the way for further breakthroughs in the synthesis of life-saving compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…